SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-013844
Filing Date
2024-02-12
Accepted
2024-02-12 09:25:50
Documents
16
Period of Report
2024-02-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm245874d1_8k.htm   iXBRL 8-K 29785
2 EXHIBIT 10.1 tm245874d1_ex10-1.htm EX-10.1 32721
  Complete submission text file 0001104659-24-013844.txt   288851

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gfor-20240209.xsd EX-101.SCH 3272
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gfor-20240209_def.xml EX-101.DEF 26915
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gfor-20240209_lab.xml EX-101.LAB 36508
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gfor-20240209_pre.xml EX-101.PRE 25539
17 EXTRACTED XBRL INSTANCE DOCUMENT tm245874d1_8k_htm.xml XML 5369
Mailing Address 3001 DAIMLER ST, SANTA ANA CA 92705
Business Address 3001 DAIMLER ST, SANTA ANA CA 92705 (949) 396-6830
NKGen Biotech, Inc. (Filer) CIK: 0001845459 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40427 | Film No.: 24617689
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)